NASDAQ·US·Drug Manufacturers - General

JNJJNJ

สรุป

เสี่ยง

ความมั่นใจ 89%
$227.35—

Today's session

Upside?
-6.8%
FV $211.82
P/E (TTM)?
26.3
Earnings yield
FCF yield?
2.3%
Mcap $547.28B

ถือ

Fundamental sell·Technical neutral

What investors notice

Key signs

Plain-language read of the metrics that matter most for this stock.

Net positive
5 · 2 · 2

Strengths

5
  • Best-in-class return on equity32%
  • High return on invested capital20%
  • EPS compounding at double-digit pace18%
  • ROIC well above cost of capital — value-creating11%
  • Analyst consensus heavily Buy-skewed

Risks

2
  • Inconsistent profitability4/10
  • Weak fundamentals signal (Piotroski ≤ 3)3/9

Watchlist

2
  • Gross margins under pressure
  • Long-term debt rising — monitor leverage
$227.35+49.9%

1Y · period change vs 2025-04-29

Score history (10y)

How quality has trended through cycles.

+1 YoY

Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.

Fair value range

5 of 5 models · trimmed-mean consensus

Consensus FV
$211.82
Upside
-6.8%
Now $227.35
Our FV$211.82
Price$227.35
$11.88$359.06

Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.

10-year financials

Annual revenue, profit, and free cash flow with year-over-year growth overlay.

YoY growth overlaid

Snapshot

At a glance

Top-line figures most investors check first.

Market cap
$547.28B
P/E (TTM)?
26.3
FCF yield?
2.3%
Dividend
$5.20
2.3% yield
52w range
$142.39 – $248.56
Score confidence
89%
Data completeness

Last updated 4/30/2026, 5:21:12 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer